Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?
Herantis Pharma phase 1b data readout

Av Inderes
Herantis Pharma announced positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease. Trial met all primary and secondary endpoints establishing a strong foundation to Phase 2.
Herantis management will host a webcast October 8th, at 13:00 EEST. The webcast will be held in English, and there will be a Q&A session in the end of the webcast. The questions are asked to be submitted in English.